Loading…
ProQR Therapeutics N.V. is projected to rise to $1.71 by 2027, a +1% move from its current price of $1.70. PRQR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.61 | $1.70 | $1.79 | 0.00% |
| Jul 14 | $1.58 | $1.70 | $1.82 | 0.00% |
| Jul 15 | $1.55 | $1.70 | $1.85 | 0.00% |
| Jul 16 | $1.53 | $1.70 | $1.88 | 0.00% |
| Jul 17 | $1.51 | $1.70 | $1.90 | 0.00% |
| Jul 18 | $1.50 | $1.70 | $1.92 | 0.00% |
| Jul 19 | $1.48 | $1.70 | $1.94 | 0.00% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.48 | $1.70 | $1.94 | 0.00% |
| Week 2 | $1.40 | $1.70 | $2.05 | -0.01% |
| Week 3 | $1.34 | $1.70 | $2.14 | -0.01% |
| Week 4 | $1.30 | $1.70 | $2.22 | -0.02% |
| Week 5 | $1.26 | $1.70 | $2.29 | -0.02% |
| Week 6 | $1.22 | $1.70 | $2.36 | -0.03% |
| Week 7 | $1.19 | $1.70 | $2.42 | -0.03% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ProQR Therapeutics N.V. is a clinical-stage biotechnology company that focuses on the discovery and development of novel therapeutic medicines. It develops an RNA editing platform through its Axiomer RNA editing technology for genetic disorders with unmet needs.
Its lead product candidate, AX-0810, targets na-taurocholate cotransporting polypeptide (NTCP) for the treatment of cholestatic diseases. It also develops AX-2402, which targets methyl CpG binding protein 2 mutations for Rett syndrome; AX-2911, which targets PNPLA3 for metabolic dysfunction-associated steatohepatitis; and AX-1412, which targets the B4GALT1 gene for cardiovascular diseases.
The company has a research and collaboration agreement with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The company was incorporated in 2012 and is headquartered in Leiden, the Netherlands.
ProQR Therapeutics N.V. (PRQR) is a healthcare stock with a current price of $1.66 and a market cap of $229.23M. It ranks 3734 by market capitalization.
The price outlook is mixed across years, with neutral sentiment in the near term and bullish sentiment emerging in later years according to the provided forecasts. The 2026 avg price is $1.66, rising toward $2.88 by 2030 and extending to $13.44 by 2050, with corresponding ROIs noted in the yearly forecasts.
A major floor 29.5% below — a decisive break under it would weaken the trend.
The nearest floor, 16.9% below — buyers have tended to step in here.
The nearest ceiling, 11.3% above — a clean break opens room to run.
A major ceiling 27.0% above — clearing it would confirm fresh momentum.
Key PRQR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PRQR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.71 | Sell | $1.73 | Sell |
| MA 10 | $1.73 | Sell | $1.72 | Sell |
| MA 20 | $1.70 | Sell | $1.70 | Buy |
| MA 50 | $1.61 | Buy | $1.66 | Buy |
| MA 100 | $1.64 | Buy | $1.69 | Buy |
| MA 200 | $1.88 | Sell | $1.79 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.67 | Neutral |
| Stoch RSI (14) | 31.47 | Neutral |
| CCI (20) | 16.36 | Neutral |
| Williams %R (14) | -44.44 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -8.47 | Sell |
| Bollinger %B (20,2) | 0.55 | Neutral |
| Stochastic %K (14) | 55.56 | Neutral |
| TRIX (15) | 0.43 | Buy |
| Awesome (5,34) | 0.09 | Buy |
| Ultimate (7,14,28) | 40.27 | Neutral |
| Momentum (10) | 0.16 | Buy |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 1.70 | Buy |
| ADX (14) | 11.64 | Neutral |
| ATR (14) | 0.08 | Info |
The 30-day technical picture is NEUTRAL with RSI14 at 50. The SMA50 is $1.60 and the SMA200 is $1.89, indicating a cautious near-term stance.
Support is at $1.41 and resistance at $1.89, framing a near-term range. The 30-day range spans from a low of $1.16 to a high of $2.38, illustrating notable short-term volatility within that band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.37 | $1.70 | $2.41 | 0% | Neutral | |
| $1.25 | $1.71 | $2.52 | +1% | Neutral | |
| $1.36 | $1.96 | $3.08 | +16% | Neutral | |
| $1.73 | $2.63 | $4.33 | +55% | Bullish | |
| $1.86 | $2.96 | $5.05 | +74% | Bullish | |
| $2.18 | $3.60 | $6.37 | +112% | Bullish | |
| $2.05 | $3.53 | $6.43 | +108% | Bullish | |
| $1.67 | $2.98 | $5.57 | +76% | Bullish | |
| $1.95 | $3.61 | $6.91 | +113% | Bullish | |
| $2.02 | $3.89 | $7.62 | +129% | Bullish | |
| $2.70 | $6.01 | $12.90 | +254% | Bullish | |
| $6.36 | $14.14 | $32.52 | +733% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.37 | $1.70 | $2.15 | +0.00% |
| August 2026 | $1.48 | $1.79 | $2.25 | +5.49% |
| September 2026 | $1.38 | $1.70 | $2.18 | -5.26% |
| October 2026 | $1.36 | $1.69 | $2.20 | -0.37% |
| November 2026 | $1.44 | $1.80 | $2.38 | +6.46% |
| December 2026 | $1.43 | $1.80 | $2.41 | +0.18% |
Click any year to see its month-by-month PRQR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect PRQR to range from $1.37 to $2.41 through 2026. The $1.70 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The PRQR price prediction for 2027 points to an average of $1.71 (low $1.25, high $2.52) — a potential gain of +1% on today's $1.70. A consolidation phase looks the most probable path here.
In 2028, PRQR is projected to trade between $1.36 and $3.08, averaging $1.96 — a potential gain of +16% from today's $1.70. That is up +15% on the projected 2027 average. Price action looks broadly range-bound.
ProQR Therapeutics N.V.'s 2029 outlook centres on $2.63, within a $1.73 to $4.33 range. That is up +34% on the projected 2028 average. That marks a +55% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, PRQR could reach as high as $5.05, with a base case around $2.96 and support toward $1.86 — roughly +74% from $1.70. Momentum favours further upside here.
Expect PRQR to range from $2.18 to $6.37 through 2031. The $3.60 average target implies a +112% move from current prices. That is up +22% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The PRQR price prediction for 2032 points to an average of $3.53 (low $2.05, high $6.43) — a potential gain of +108% on today's $1.70. Momentum favours further upside here.
In 2033, PRQR is projected to trade between $1.67 and $5.57, averaging $2.98 — a potential gain of +76% from today's $1.70. That is -16% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
ProQR Therapeutics N.V.'s 2034 outlook centres on $3.61, within a $1.95 to $6.91 range. That is up +21% on the projected 2033 average. That marks a +113% change versus current levels. Momentum favours further upside here.
By 2035, PRQR could reach as high as $7.62, with a base case around $3.89 and support toward $2.02 — roughly +129% from $1.70. Buyers look set to stay in control over this stretch.
Expect PRQR to range from $2.70 to $12.90 through 2040. The $6.01 average target implies a +254% move from current prices. That is up +55% on the projected 2035 average. Momentum favours further upside here.
The PRQR price prediction for 2050 points to an average of $14.14 (low $6.36, high $32.52) — a potential gain of +733% on today's $1.70. Buyers look set to stay in control over this stretch.
Investing $1,000 in PRQR today (≈ 589.03222 PRQR) could be worth
$8,327.6
+$7,327.6 (+733%) by 2050 · US Dollar
Based on the average projected PRQR price of $14.14 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PRQRwould be worth at today's price.
$1,000 invested in PRQR on Jul 10, 2025 (≈ 423.728832 PRQR) would be worth
$719.36
-$280.64 (-28.1%) today · 0.72× · US Dollar
Based on a PRQR entry price of $2.36 vs. today's $1.7.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.81 | $937.96 | -6.2% |
| 1 month ago | $1.41 | $1,204.04 | +20.4% |
| 3 months ago | $1.85 | $917.68 | -8.2% |
| 6 months ago | $1.68 | $1,010.54 | +1.1% |
| 1 year ago | $2.36 | $719.36 | -28.1% |
| All time (5.0y) ago | $6.13 | $276.95 | -72.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PRQR forecast.
Our base-case forecast reaches $3.40 around 2031.
Implied market cap at $3.40: $479.81M
The multi-year forecast shows a bullish trajectory over time. By 2029 the average price is $2.53 with a 52.6% ROI and a BULLISH sentiment, climbing to 2030 with an avg of $2.88 and a 73.2% ROI. The bullish trend strengthens into 2040 with an avg of $5.71 and a 244.1% ROI, and extends to 2050 with an avg of $13.44 and a 709.8% ROI.
These figures indicate meaningful upside potential over the long term, alongside the inherent uncertainty of carrying this level of exposure.
These are estimates, not guarantees, and actual results may differ due to market conditions and other factors.
Tap a question to reveal the answer.
The 2030 forecast lists an average price of $2.88 with a 73.2% ROI and a BULLISH sentiment.
The forecast shows a path from neutral in earlier years to bullish in later years, with 2029 avg $2.53 and 2030 avg $2.88 (ROI 52.6% and 73.2% respectively), but these are estimates and not guarantees.
Yes. The 2050 forecast shows a max of $30.92 with a 709.8% ROI and a BULLISH sentiment.
The 30-day range is from $1.16 to $2.38, with support at $1.41 and resistance at $1.89.
ProQR Therapeutics N.V. Community Discussion
0Share your ProQR Therapeutics N.V. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.